Security key
68062P106
Olema Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (OLMA)
CUSIP: 68062P106
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 91,696,172
- Total 13F shares
- 71,278,859
- Share change
- +10,428,389
- Total reported value
- $415,382,388
- Put/Call ratio
- 0.55%
- Price per share
- $5.83
- Number of holders
- 154
- Value change
- +$48,509,843
- Number of buys
- 81
- Number of sells
- 48
Report period
Q4 2024
Institutions
154
Top holders
10
OLMA full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Olema Pharmaceuticals, Inc. SEC filings
Olema Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 68062P106
Recent filing periods:
Top shareholders of OLMA - Olema Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Paradigm Biocapital Advisors LP |
3/4/5
13D/G
13F
|
10%+ Owner · Company |
10%
from 13D/G
|
13,407,200
|
$173,767,954 | — | 01 Aug 2024 | |
| BVF INC/IL |
13F
|
Company |
10%
|
9,135,893
|
$109,082,562 | — | 30 Sep 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
4.4%
|
4,000,000
|
$47,760,000 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
4.2%
|
3,847,471
|
$45,938,804 | — | 30 Sep 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
4%
|
3,687,374
|
$44,027,246 | — | 30 Sep 2024 | |
| Logos Global Management LP |
13F
|
Company |
3.5%
|
3,208,875
|
$38,313,968 | — | 30 Sep 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
2.9%
|
2,680,596
|
$32,006,316 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.8%
|
2,532,892
|
$30,242,731 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
1,969,963
|
$23,521,358 | — | 30 Sep 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.8%
|
1,667,459
|
$19,909,460 | — | 30 Sep 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
1.6%
|
1,506,764
|
$17,989,956 | — | 30 Sep 2024 | |
| Vivo Capital, LLC |
13F
|
Company |
1.6%
|
1,505,862
|
$17,979,992 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.5%
|
1,376,924
|
$16,441,761 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.5%
|
1,354,186
|
$16,168,981 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.4%
|
1,252,745
|
$14,957,776 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.1%
|
1,002,685
|
$11,972,059 | — | 30 Sep 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
1.1%
|
1,000,000
|
$11,940,000 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
934,929
|
$11,165,286 | — | 30 Sep 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.93%
|
851,512
|
$10,167,053 | — | 30 Sep 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.77%
|
709,097
|
$8,466,618 | — | 30 Sep 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
0.71%
|
650,000
|
$7,761,000 | — | 30 Sep 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.58%
|
535,000
|
$6,387,900 | — | 30 Sep 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.51%
|
463,124
|
$5,529,701 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.5%
|
462,347
|
$5,520,423 | — | 30 Sep 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.5%
|
461,926
|
$5,515,395 | — | 30 Sep 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.5%
|
455,082
|
$5,433,679 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.45%
|
410,939
|
$4,906,612 | — | 30 Sep 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.44%
|
400,000
|
$4,776,000 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.43%
|
389,734
|
$4,653,424 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.36%
|
330,761
|
$3,949,286 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.27%
|
249,601
|
$2,980,236 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.26%
|
240,387
|
$2,870,220 | — | 30 Sep 2024 | |
| HighVista Strategies LLC |
13F
|
Company |
0.23%
|
212,185
|
$2,533,489 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.2%
|
181,032
|
$2,161,522 | — | 30 Sep 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.19%
|
176,663
|
$2,109,356 | — | 30 Sep 2024 | |
| Newtyn Management, LLC |
13F
|
Company |
0.15%
|
140,000
|
$1,671,600 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.14%
|
132,182
|
$1,578,254 | — | 30 Sep 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.13%
|
120,093
|
$1,433,910 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.13%
|
118,434
|
$1,414,102 | — | 30 Sep 2024 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.13%
|
117,595
|
$1,404,084 | — | 30 Sep 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.12%
|
108,852
|
$1,299,000 | — | 30 Sep 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.11%
|
103,500
|
$1,235,790 | — | 30 Sep 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.11%
|
101,200
|
$1,208,328 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.11%
|
100,047
|
$1,194,561 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.1%
|
94,915
|
$1,133,286 | — | 30 Sep 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.1%
|
92,000
|
$1,098,479 | — | 30 Sep 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.1%
|
90,475
|
$1,080,272 | — | 30 Sep 2024 | |
| Dana Investment Advisors, Inc. |
13F
|
Company |
0.09%
|
85,807
|
$1,024,536 | — | 30 Sep 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.09%
|
82,187
|
$1,001,860 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.09%
|
78,060
|
$932,036 | — | 30 Sep 2024 |
Institutional Holders of Olema Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (OLMA) as of Q4 2024
As of 31 Dec 2024,
Olema Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (OLMA) was held by
154 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
71,278,859 shares.
The largest 10 holders included
Bain Capital Life Sciences Investors, LLC, Paradigm Biocapital Advisors LP, BVF INC/IL, BlackRock, Inc., Point72 Asset Management, L.P., Deep Track Capital, LP, Logos Global Management LP, MPM BIOIMPACT LLC, VANGUARD GROUP INC, and LIGHTSPEED MANAGEMENT COMPANY, L.L.C..
This page lists
154
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
129
Q4 2024 holders
154
Holder diff
25
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.